Eculizumab Shows Better Prolonging of Time to NMOSD Relapse Than Other Treatments
October 17, 2021 – Marco Meglio An indirect comparison study evaluated relative treatment effects of eculizumab (Soliris; Alexion), inebilizumab (Uplizna; Horizon),…
Considerations for the Use of Fumarates in Relapsing MS
July 24, 2021 Fred D. Lublin, MD, Ravi Dukkipati, MD, Gavin Giovannoni, MD , Lauren Gluck, MD CLICK IMAGE TO…
Stuart Schlossman
Anti-CD20 Agents for Relapsing MS
July 24, 2021 Fred D. Lublin, MD, Ravi Dukkipati, MD, Gavin Giovannoni, MD , Lauren Gluck, MD A panel of experts discuss the use…
Stuart Schlossman
